Menopausal Hormone Therapy and the Role of Estrogen
- PMID: 34231526
- DOI: 10.1097/GRF.0000000000000648
Menopausal Hormone Therapy and the Role of Estrogen
Abstract
Menopause is a universal experience for midlife women. The physiological decline in endogenous estrogen can be associated with vasomotor symptoms or hot flashes, sleep disruption, and mood disorders. Long-term concerns arise with sequelae of estrogen loss such as genitourinary syndrome of menopause and osteoporosis. Although the pendulum has swung widely since the 1942 approval of conjugated equine estrogens, estrogen therapy, now available in an ever-expanding menu of preparations, routes of administration, and dosing, remains the most effective means to collectively address these, and potentially, additional concerns. Refinement of knowledge of risks and benefits facilitates patient selection and counseling.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop+10 addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19:387–395.
-
- Santoro N, Roeca C, Peters BA, et al. The menopause transition: signs, symptoms, and management options. J Clin Endocrinol Metab. 2021;106:1–15.
-
- The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause. 2020;27:976–992.
-
- Kling JM, MacLaughlin JL, Schnatz PF, et al. Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: a cross-sectional survey. Mayo Clin Proc. 2019;94:242–253.
-
- Truong SR, Wolff J, Keenan T, et al. A survey of menopause care among US women. J Gynecol Obstet. 2019;7:31–35.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
